Description
Iv0019 is a monoclonal antibody that neutralizes interleukin-1 beta (IL-1β), a central mediator of inflammation. By blocking IL-1β, Iv0019 reduces inflammatory responses and is used in research to study autoinflammatory conditions such as CAPS, TRAPS, FMF, Still’s disease, and gout flares.